Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | RASSF5 |
| Upstream (Parents) |
|---|
| (<<) ARHGAP25 → RASSF5 |
| (<<) CORO1A → RASSF5 |
| (<<) INPP5D → RASSF5 |
| (<<) IRF1 → RASSF5 |
| (<<) JAK3 → RASSF5 |
| (<<) LTB → RASSF5 |
| (<<) PIK3CG → RASSF5 |
| (<<) PSTPIP1 → RASSF5 |
| (<<) STAT4 → RASSF5 |
| (<<) VAV1 → RASSF5 |
| Downstream (Children) |
|---|
| RASSF5 → BLNK (>>) |
| RASSF5 → CASP4 (>>) |
| RASSF5 → CBFA2T3 (>>) |
| RASSF5 → CCND2 (>>) |
| RASSF5 → CD79A (>>) |
| RASSF5 → CEACAM1 (>>) |
| RASSF5 → CHST10 (>>) |
| RASSF5 → CHST2 (>>) |
| RASSF5 → CSTA (>>) |
| RASSF5 → EFHD2 (>>) |
| RASSF5 → ELF1 (>>) |
| RASSF5 → EPHA4 (>>) |
| RASSF5 → HOPX (>>) |
| RASSF5 → HSD11B1 (>>) |
| RASSF5 → ITGB7 (>>) |
| RASSF5 → LOC650392 (>>) |
| RASSF5 → MAL (>>) |
| RASSF5 → MAP3K14 (>>) |
| RASSF5 → NRIP3 (>>) |
| RASSF5 → PIP4K2A (>>) |
| RASSF5 → PLOD2 (>>) |
| RASSF5 → POP1 (>>) |
| RASSF5 → PRKACB (>>) |
| RASSF5 → PRKCB (>>) |
| RASSF5 → PRKCH (>>) |
| RASSF5 → RNF138 (>>) |
| RASSF5 → S100P (>>) |
| RASSF5 → SGMS2 (>>) |
| RASSF5 → SOX8 (>>) |
| RASSF5 → ST3GAL6 (>>) |
| RASSF5 → STAT6 (>>) |
| RASSF5 → STEAP1 (>>) |
| RASSF5 → STK17A (>>) |
| RASSF5 → TRAF1 (>>) |
| RASSF5 → ZBED2 (>>) |
